A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.

Also called NCT07754461

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 600 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07754461
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Australia, Canada, India, New Zealand, Puerto Rico (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07754461. Randomized; quadruple masking; primary purpose treatment. Start 2026-08-24 (actual); primary completion 2028-01-17 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Intervention (Drug)
Placebo
Intervention (Drug)
Survodutide
Lead sponsor
Boehringer Ingelheim (class: industry)

Record details

Record id
cardio:ct-nct07754461
Content hash
250a49d6277052e2e41f298cd9b3a09209914cffff2efa5a0e64524cf705a999